CLARIFIDE, a new genomic test for comprehensive evaluation of dairy females, is now available from Pfizer Animal Genetics, a business unit of Pfizer Animal Health.
CLARIFIDE is a 3,000-marker (3K) DNA panel that was developed through collaboration between USDA-ARS and Illumina. CLARIFIDE delivers Genomic Predicted Transmitting Ability (GPTA) values for 30 production, health and type traits, and nine composite indexes. These predictions provide insights into animals’ future genetic potential early in an animal’s life.
“CLARIFIDE provides a cost-effective way for commercial dairy producers to take advantage of the many benefits of genomic testing,” says Nigel Evans, vice president of Pfizer Animal Genetics. “Genomics has been available in the dairy industry for the past few years, but has only been practical for a small number of elite animals. CLARIFIDE now puts genomic testing into the hands of commercial dairymen.”
With CLARIFIDE, commercial dairy producers can optimize selection, mating and management of Holstein, Jersey and Brown Swiss females.… Continue readingRead More »